Literature summary for 3.4.21.110 extracted from

Santillan, D.A.; Rai, K.K.; Santillan, M.K.; Krishnamachari, Y.; Salem, A.K.; Hunter, S.K.
Efficacy of polymeric encapsulated C5a peptidase-based group B streptococcus vaccines in a murine model (2011), Am. J. Obstet. Gynecol., 205, 249e1-249e8.

Application

Application	Comment	Organism
medicine	encapsulated C5a peptidase elicits significant immune responses and protection against a group B Streptococcus challenge. C5a peptidase poly(lactide-coglycolide) microsphere encapsulation has potential as a group B Streptococcus vaccine	Streptococcus sp.

Organism	UniProt	Comment	Textmining
Streptococcus sp.	-	group B	-

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)